GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with INS(1,4,5)P3 and ADP

Analyse Crystal structure of the core catalytic domain of human inositol phosphate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5W2H
Type
protein
Length
237 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Inositol polyphosphate MULTIKINASE,INOSITOL polyphosphate multikinase
EC
2.7.1.151
UniProt
Q8NFU5
Ligands
ADP, I3P, MG, PO4
Pockets
2 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInositol polyphosphate MULTIKINASE,INOSITOL polyphosphate multikinase (EC 2.7.1.151)protein23736% helix, 27% strandQ8NFU5

Ligands and binding sites

  • ADP · Adenosine-5'-diphosphate · ligand · chains A
  • I3P · D-myo-inositol-1,4,5-triphosphate · ligand · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12240.540.7722MG, ADP
21170.410.7618MG, I3P

Compared structures

  • 5W2H · Crystal structure of the core catalytic domain of human inositol phosphate multikinase in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8NFU5 · AlphaFold monomer V2.0 prediction for inositol polyphosphate multikinase (Q8NFU5) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.